The American Society of Hematology sent
their update today. All rather clinical (rather than technical), and
with a serious focus on the money, but something for nothing is always good.
 | FDA Approves Oliceridine for Management of Acute Pain The intravenous opioid is approved for use in hospitals and other controlled clinical settings, not for at-home treatment, at a maximum recommended daily dose of 27 mg. |
 |
New Cancer Diagnoses Dropped by Nearly Half During Pandemic A recent study reported a 46.4% average decline in new cancer diagnoses for six common cancer types between March and April 2020, including a 51.8% drop in new breast cancer cases. |
 |
Poll Finds 35% of Americans Would Decline COVID-19 Vaccine A new Gallup poll found that nearly two-thirds of Americans would agree to receive an FDA-approved COVID-19 vaccine at no cost, with slight disparities according to age, race, and location. |
No comments:
Post a Comment